Evidence map›Paper›PMID 33441539›Full record

SynthesisTranslational psychiatry2021

Emerging behavioral and neuroimaging biomarkers for early and accurate characterization of autism spectrum disorders: a systematic review.

Chandrakanta S Hiremath, Kommu John Vijay Sagar, B K Yamini, Akhila S Girimaji, Raghavendra Kumar, Sanivarapu Lakshmi Sravanti, Hansashree Padmanabha, K N Vykunta Raju, M Thomas Kishore, Preeti Jacob and 4 more

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cell death-associated genes as novel diagnostic biomarkers for autism spectrum disorder.Apoptosis : an international journal on programmed cell death · 2026
    Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Chandrakanta S HiremathDepartment of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Kommu John Vijay SagarDepartment of Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.
B K YaminiDepartment of Speech Pathology and Audiology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Akhila S GirimajiDepartment of Speech Pathology and Audiology, National Institute of Mental Health and Neurosciences, Bengaluru, India.ORCID http://orcid.org/0000-0002-8495-6987
Raghavendra KumarDepartment of Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Sanivarapu Lakshmi SravantiDepartment of Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.ORCID http://orcid.org/0000-0003-3979-9609
Hansashree PadmanabhaDepartment of Neurology, National Institute of Mental Health and Neuroscience, Bengaluru, India.
K N Vykunta RajuDepartment of Pediatric Neurology, Indira Gandhi Institute of Child Health, Bengaluru, India.
M Thomas KishoreDepartment of Clinical Psychology, National Institute of Mental Health and Neuroscience, Bengaluru, India.ORCID http://orcid.org/0000-0002-8000-169X
Preeti JacobDepartment of Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Jitender SainiDepartment of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Rose D BharathDepartment of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Shekhar P SeshadriDepartment of Child and Adolescent Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Manoj KumarDepartment of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bengaluru, India. vermanojk@gmail.com.ORCID http://orcid.org/0000-0002-2729-7049
National Institute of Mental Health and Neurosciences · INIndira Gandhi Institute of Child Health · IN

Funding

Department of Biotechnology, Ministry of Science and Technology (DBT) BT/RLF/Reentry/16/2015) (D.O. No. BT/HRD/35/02/2006
6 · The paper itself

Abstract

The possibility of early treatment and a better outcome is the direct product of early identification and characterization of any pathological condition. Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by impairment in social communication, restricted, and repetitive patterns of behavior. In recent times, various tools and methods have been developed for the early identification and characterization of ASD features as early as 6 months of age. Thorough and exhaustive research has been done to identify biomarkers in ASD using noninvasive neuroimaging and various molecular methods. By employing advanced assessment tools such as MRI and behavioral assessment methods for accurate characterization of the ASD features and may facilitate pre-emptive interventional and targeted therapy programs. However, the application of advanced quantitative MRI methods is still confined to investigational/laboratory settings, and the clinical implication of these imaging methods in personalized medicine is still in infancy. Longitudinal research studies in neurodevelopmental disorders are the need of the hour for accurate characterization of brain-behavioral changes that could be monitored over a period of time. These findings would be more reliable and consistent with translating into the clinics. This review article aims to focus on the recent advancement of early biomarkers for the characterization of ASD features at a younger age using behavioral and quantitative MRI methods.

Indexed as

Autism Spectrum DisorderBiomarkersBrainHumansMagnetic Resonance ImagingNeuroimagingBiomarkers

Identifiers

PMID33441539
PMCPMC7806884
OpenAlexW3118678801

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.